Prollenium Medical Technologies Inc.
George Rizis is a Principal Scientist at Prollenium Medical Technologies Inc. since September 2025, with previous experience as a Senior Scientist at Covalon Technologies Ltd. from January 2021 to September 2025, and as a Research Scientist at Ripple Therapeutics from December 2019 to January 2021. Prior to these roles, George worked as a Research Chemist at Interface Biologics from August 2016 to January 2021 and served as a Postdoctoral Fellow at UC Santa Barbara and McGill University. George began a career in pharmaceutical analysis as an Analyst at MDS Pharma Services from September 2004 to May 2007, focusing on quantitative analysis of drugs and metabolites using liquid chromatography and tandem mass spectrometry. Academically, George holds a PhD in Polymer Chemistry and a BSc in Biochemistry, both from McGill University.
This person is not in any teams
This person is not in any offices